Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.59 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.54 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20901037 | 1.00 | SLC6A4 (0.59) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| SCHEMBL21151797 | 1.00 | SLC6A4 (0.59) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| SCHEMBL14168918 | 1.00 | SLC6A4 (0.59) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL17315608 | 0.96 | SLC6A4 (0.54) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| SCHEMBL11972187 | 0.94 | SLC6A4 (0.51) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL18742725 | 0.92 | SLC6A4 (0.50) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| SCHEMBL895814 | 0.90 | MAOB (0.52) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL18742650 | 0.88 | MAOB (0.50) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B | |
| SCHEMBL17315712 | 0.84 | MAOB (0.55) | — | |
| SCHEMBL23647427 | 0.81 | MAOB (0.44) | SLC6A4SLC6A3GRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10259969-B2 | Paramagnetic supports for use as assay reagents | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10259969-B2 | Paramagnetic supports for use as assay reagents | PUF60, MAG, HMBS | SLC6A4 4236/4885SLC6A3 2962/4885GRIN1 1568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.